Evidence map›Paper›PMID 38078722›Full record

ArticleMicrobiology spectrum2024

Mobile class A β-lactamase gene

Hirokazu Yano, Masato Suzuki, Lisa Nonaka

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Characterization of BAS-1, a novel class A β-lactamase encoded inAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nationwide genome surveillance of carbapenem-resistantAntimicrobial agents and chemotherapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hirokazu YanoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases , Higashimurayama, Tokyo, Japan.ORCID 0000-0001-5144-3459
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases , Higashimurayama, Tokyo, Japan.ORCID 0000-0001-8975-2193
Lisa NonakaFaculty of Human Life Sciences, Shokei University , Kumamoto, Japan.ORCID 0000-0003-0881-4626
National Institute of Infectious Diseases · JPShokei College · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP23gm1610003, JP23fk0108642, JP23fk0108665, JP23fk0108683, JP23wm0325037, JP23wm0225022, JP23wm0225029MEXT | Japan Society for the Promotion of Science (JSPS) 18K05790, 22K05790MEXT | Japan Society for the Promotion of Science (JSPS) 23K06556Mishima Kaiun Memorial FoundationOhsumi Frontier Science Foundation (OFSF)
6 · The paper itself

Abstract

importanceDespite increasing reports, class A β-lactamases of environmental bacteria remain very poorly characterized, with limited understanding of their transmission patterns. To address this knowledge gap, we focused on a recently designated GMA family β-lactamase gene,

Indexed as

Anti-Bacterial Agentsbeta-LactamasesGenes, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesGMA-1GMA familypenicillinaseplasmidSEVibrio

Identifiers

PMID38078722
PMCPMC10782965
OpenAlexW4389558937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.